Literature DB >> 3202036

Coronary events in the Hunter region of New South Wales, Australia: 1984-1986.

A J Dobson1, H M Alexander, K Al-Roomi, R W Gibberd, R F Heller, S R Leeder, D M Lloyd, J A Malcolm, P L Steele.   

Abstract

The results of coronary event registration using the protocol of the World Health Organization MONICA Project are reported for two years for the Hunter Region, the area in and around Newcastle in New South Wales, Australia. The Newcastle MONICA Project monitors all suspected cases of heart attack by identifying patients from hospital admissions and obtaining information while they are still in hospital. For people who die out of hospital, the initial source of information is usually the death certificate. Rates for the most robust MONICA diagnostic categories, non-fatal definite myocardial infarction and all coronary deaths, differed for the two years reported here. Monthly rates suggested possible seasonal effects, and the possible influence of lower respiratory infections including an epidemic of influenza A. The results demonstrate that consistent monitoring over several years will be necessary to establish clear trends in coronary heart disease.

Entities:  

Mesh:

Year:  1988        PMID: 3202036     DOI: 10.1111/j.0954-6820.1988.tb05558.x

Source DB:  PubMed          Journal:  Acta Med Scand Suppl        ISSN: 0365-463X


  3 in total

1.  Influenza vaccination, pneumococcal vaccination and risk of acute myocardial infarction: matched case-control study.

Authors:  A Niroshan Siriwardena; Stella M Gwini; Carol A C Coupland
Journal:  CMAJ       Date:  2010-09-20       Impact factor: 8.262

2.  Seasonality of coronary artery deaths in New South Wales, Australia.

Authors:  D P Weerasinghe; C R MacIntyre; G L Rubin
Journal:  Heart       Date:  2002-07       Impact factor: 5.994

3.  Success of cardiopulmonary resuscitation after heart attack in hospital and outside hospital.

Authors:  R F Heller; P L Steele; J D Fisher; H M Alexander; A J Dobson
Journal:  BMJ       Date:  1995-11-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.